Phospholipid-based nano drug delivery system of curcumin using MSP1D1 protein and poloxamer 407: a comparative study for targeted drug delivery to the brain

Springer Science and Business Media LLC - Tập 26 - Trang 1-18 - 2024
Mohammad Hossain Shariare1, Mahbia Mannan1, Fairouz Khan1, Ayesha Sharmin2, Mohamed W. Attwa3, A. F. M. Motiur Rahman3, Mahbubur Rahman1, Mohammad N. Uddin4, Mohsin Kazi5
1Department of Pharmaceutical Sciences, North South University, Dhaka, Bangladesh
2Department of Chemistry, Bangladesh University of Engineering & Technology (BUET), Dhaka, Bangladesh
3Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh, Kingdom of Saudi Arabia
4Department of Pharmaceutical Sciences, College of Pharmacy, Mercer University, Atlanta, USA
5Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Kingdom of Saudi Arabia

Tóm tắt

This study aims to investigate a potential alternative for MSP1D1 protein to develop a lipid polymer hybrid nanoparticle (LPHN) system of curcumin using poloxamer 407 and its targeted drug delivery to the brain. Design of experiment (DoE) was used to optimize the lipid nanodisc and LPHN delivery system of curcumin by the thin film hydration method. Solid-state characterization of the optimized lipid nanodiscs and LPHNs was performed using DLS, TEM, SEM, PXRD, and DSC. In vitro release, stability study, and in vivo anti-inflammatory and bioavailability studies in mice brains were performed for the optimized LPHN delivery system. DLS and microscopic data showed that the average sizes of the lipid nanodisc and LPHN systems were 125–198 nm and 135–240 nm, respectively. The LPHN delivery system of curcumin exhibited high entrapment efficiency (95.7 ± 2.2%) compared to lipid nanodiscs (91.2 ± 1.7%). In vitro release data showed slow release of lipid nanodiscs and LPHN systems, particularly after 72 h (47.6% and 37.6%, respectively). Stability data indicated that the LPHN delivery system of curcumin was stable after 3 months, while significant growth in size was observed for lipid nanodiscs. PXRD and DSC results showed the partial amorphization of the LPHN system. In vivo anti-inflammatory data suggested that curcumin has anti-inflammatory activity when delivered as an LPHN system. In vivo bioavailability study showed curcumin (6.3 ng/mL) in brain homogenates of mice treated with the LPHN delivery system, suggesting its potential for targeting the brain to treat neurodegenerative diseases.

Tài liệu tham khảo

Sun M, Su X, Ding B, He X, Liu X, Yu A, Lou H, Zhai G (2012) Advances in nanotechnology-based delivery systems for curcumin. Nanomedicine 7(7):1085–1100 Anand P, Thomas SG, Kunnumakkara AB et al (2008) Biological activities of curcumin and its analogs (congeners) made by man and mother nature. Biochem Pharmacol 76(11):1590–1611 Begum AN, Jones MR, Lim GP, Morihara T, Kim P, Heath DD, Frautschy SA (2008) Curcumin structure-function, bioavailability, and efficacy in models of neuroinflammation and Alzheimer’s disease. J Pharm and Experim Therap 326(1):196–208 Mishra S, Palanivelu K (2008) The effect of curcumin (turmeric) on Alzheimer’s disease: an overview. Ann Indian Acad Neurol 11(1):13–19 Tønnesen HH, Másson M, Loftsson T (2002) Studies of curcumin and curcuminoids. XXVII. Cyclodextrin complexation: solubility, chemical and photochemical stability. Int J Pharm 244(1–2):127–135 Hu L, Shi Y, Li JH et al (2015) Enhancement of oral bioavailability of curcumin by a novel solid dispersion system. AAPS PharmSciTech 16:1327–1334 Wang YJ, Pan MH, Cheng AL et al (1997) Stability of curcumin in buffer solutions and characterization of its degradation products. J Pharm Biomed Anal 15(12):1867–1876 Holder GM, Plummer JL, Ryan AJ (1978) The metabolism and excretion of curcumin (1,7-bis-(4-hydroxy-3-methoxyphenyl)-1,6- heptadiene-3,5-dione) in the rats. Xenobiotica 8(12):761–768 Ravindranath V, Chandrasekhara N (1981) In vitro studies on the intestinal absorption of curcumin in rats. Toxicology 20(2–3):251–257 Chuang SY, Lin CH, Huang TH, Fang JY (2018) Lipid-based nanoparticles as a potential delivery approach in the treatment of rheumatoid arthritis. Nanomaterials 8(1):42 Kesisoglou F, Panmai S, Wu Y (2007) Nanosizing — oral formulation development and biopharmaceutical evaluation. Adv Drug Delivery Rev 59(7):631–644 Ravula T, Hardin NZ, Ramadugu SK, Ramamoorthy A (2017) pH tunable and divalent metal ion tolerant polymer lipid nanodiscs. Langmuir 33(40):10655–10662 Ghosh M, Singh ATK, Xu W, Sulchek T, Gordon LI, Ryan RO (2011) Curcumin nanodisks: formulation and characterization. Nanomed: Nanotechnol Biol Med 7(2):162–167 Arya GS, Kumar AA, Nair AJ, Raju J, Nair SC (2019) Nanodisc: a new approach in the study of membrane proteins and as an emerging drug delivery system. Int J of Appl Pharmaceutics 11(1):1 Denisov IG, Grinkova YV, Lazarides AA, Sligar SG (2004) Directed self-assembly of monodisperse phospholipid bilayer nanodiscs with controlled size. J Am Chem Soc 126(11):3477–3487 Ghosh M, Singh AT, Xu W, Sulchek T, Gordon LI, Ryan RO (2011) Curcumin nanodisks: formulation and characterization. Nanomedicine 7(2):162–167 Li Z, Xiong X, Peng S, Chen X, Liu W, Liu C (2020) Novel folated pluronic F127 modified liposomes for delivery of curcumin: preparation, release, and cytotoxicity. J Microencapsulation 37(3):220–229 Li Z, Huang Y, Peng S, Chen X, Zou L, Liu W, Liu C (2020) Liposomes consisting of pluronic F127 and phospholipid: effect of matrix on morphology, stability and curcumin delivery. J Dispersion Sci Technol 41(2):207–213 Li ZL, Peng SF, Chen X, Zhu YQ, Zou LQ, Liu W, Liu CM (2018) Pluronics modified liposomes for curcumin encapsulation: sustained release, stability and bioaccessibility. Food Res Int 108:246–253 Hadinoto K, Sundaresan A, Cheow WS (2013) Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review. Eur J Pharm Biopharm 85:427–443 Mukherjee A, Waters AK, Kalyan P, Achrol AS, Kesari S, Yenugonda VM (2019) Lipid-polymer hybrid nanoparticles as a next-generation drug delivery platform: state of the art, emerging technologies, and perspectives. Int J Nanomedicine 19(14):1937–1952 De Leo V, Di Gioia S, Milano F, Fini P, Comparelli R, Mancini E, Agostiano A, Conese M, Catucci L (2020) Eudragit S100 entrapped liposome for curcumin delivery: anti-oxidative effect in Caco-2 cells. Coatings 10:114 Malvajerd SS, Azadi A, Izadi Z, Kurd M, Dara T, Dibaei M, Zadeh MS, Javar HK, Hamidi M (2019) Brain delivery of curcumin using solid lipid nanoparticles and nanostructured lipid carriers: preparation, optimization, and pharmacokinetic evaluation. ACS Chem Neurosci 10(1):728–739 Garg NK, Tandel N, Jadon RS, Tyagi RK, Katare OP (2018) Lipid-polymer hybrid nanocarrier-mediated cancer therapeutics: current status and future directions. Drug Discov Today 23(9):1610–1621 Rushmi ZT, Akter N, Mow RJ, Afroz M, Kazi M, de Matas M, Rahman M, Shariare MH (2017) The impact of formulation attributes and process parameters on black seed oil loaded liposomes and their performance in animal models of analgesia. Saudi Pharm J 25(3):404–412 Kumari P, Muddineti OS, Rompicharla SVK, Ghanta P, Karthik BBN, Ghosh B, Biswas S (2017) Cholesterol-conjugated poly (D, L-lactide)-based micelles as a nanocarrier system for effective delivery of curcumin in cancer therapy. Drug Delivery 24(1):209–223 Feng T, Wei Y, Lee RJ, Zhao L (2017) Liposomal curcumin and its application in cancer. Int J Nanomed 12:6027–6044 Ramana LN, Sethuraman S, Ranga U, Krishnan U (2010) Development of a liposome nanodelivery system for Nevirapine. J Biomed Sci 17:57 Cheng C et al (2019) Improvement on stability, loading capacity and sustained release of rhamnolipids modified curcumin liposomes. Colloids and Surfaces B Biointerfaces 183:110460 Li R, Deng L, Cai Z, Zhang S, Wang K, Li L, Ding S, Zhou C (2017) Liposomes coated with thiolated chitosan as drug carriers of curcumin. Mater Sci Eng 80:156–164 Shariare MH, Noor HB, Khan JH, Uddin J, Ahamad SR, Altamimi MA, Alanazi FK, Kazi M (2021) Liposomal drug delivery of Corchorus olitorius leaf extract containing phytol using design of experiment (DoE): in vitro anticancer and in vivo anti-inflammatory studies. Colloids Surf B Biointerfaces 199:111543 Schiborr C, Eckert GP, Rimbach G, Frank J (2010) A validated method for the quantification of curcumin in plasma and brain tissue by fast narrow-bore high-performance liquid chromatography with fluorescence detection. Anal Bioanal Chem 397(5):1917–1925 Denisov IG, Sligar SG (2017) Nanodiscs in membrane biochemistry and biophysics. Chem Rev 117:4669–4713 Stepien P, Augustyn B, Poojari C, Galan W, Polit A, Vattulainen I, Wisnieska-Becker A, Rog T (2020) Complexity of seemingly simple lipid nanodiscs. Biochim Biophys Acta Biomembr 1862(11):183420 Pandey AK, Piplani N, Mondal T, Katranidis A, Bhattacharya J (2021) Efficient delivery of hydrophobic drug, cabazitaxel, using nanodisc: a nano sized free standing planar lipid bilayer. J Mol Liq 339:116690 Cafaggi S, Leardi R, Parodi B, Caviglioli G, Russo E, Bignardi G (2005) Preparation and evaluation of a chitosan salt–poloxamer 407 based matrix for buccal drug delivery. J Controlled Release 102(1):159–169 Damiati S, Scheberl A, Zayni S, Damiati SA, Schuster B, Kompella UB (2019) Albumin-bound nanodiscs as delivery vehicle candidates: development and characterization. Biophys Chem 251:106178 Mandal I, Bhattacharjee H, Mittal N, Sah H, Balabathula P, Laura A, Thoma Wood GC (2013) Core–shell-type lipid–polymer hybrid nanoparticles as a drug delivery platform. Nanomed: Nanotechnol Biol Med 9(4):474–491 Mohanty C, Sahoo SK (2010) The in vitro stability and in vivo pharmacokinetics of curcumin prepared as an aqueous nanoparticulate formulation. Biomaterials 31(25):6597–6611 Gao J, Ming J, He B, Fan Y, Gu Z, Zhang X (2008) Preparation and characterization of novel polymeric micelles for 9-nitro-20(S)-camptothecin delivery. Eur J Pharm Sci 34(2–3):85–93